Covered recipient · General Payments record
JOHN M LAWSON
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2018–2024
$2,729.37
- Reported across 136 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $289.13 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $225.33 | 15 |
| Janssen Biotech, Inc. | $28.66 | 1 |
| Ferring Pharmaceuticals Inc. | $20.67 | 1 |
| EVOKE PHARMA, INC. | $14.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.11 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144664 | CMS |
| ABBVIE INC. | $22.15 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144666 | CMS |
| ABBVIE INC. | $14.33 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144668 | CMS |
| ABBVIE INC. | $1.04 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144670 | CMS |
| ABBVIE INC. | $17.08 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144672 | CMS |
| ABBVIE INC. | $7.42 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144674 | CMS |
| ABBVIE INC. | $18.83 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144676 | CMS |
| ABBVIE INC. | $6.19 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144678 | CMS |
| ABBVIE INC. | $11.60 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144680 | CMS |
| ABBVIE INC. | $15.02 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144682 | CMS |
| ABBVIE INC. | $16.54 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144684 | CMS |
| ABBVIE INC. | $22.56 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144686 | CMS |
| ABBVIE INC. | $26.53 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144688 | CMS |
| ABBVIE INC. | $22.29 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144690 | CMS |
| ABBVIE INC. | $4.64 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104144692 | CMS |
| EVOKE PHARMA, INC. | $14.47 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127776599 | CMS |
| Ferring Pharmaceuticals Inc. | $20.67 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137489977 | CMS |
| Janssen Biotech, Inc. | $28.66 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078795516 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.